Pharma BD Deal Intelligence
Endo Pharmaceuticals Holdings Inc. / Penwest Pharmaceuticals Co.
2010 · Acquisition/Merger · $144M · Complete
Announcement Sentiment
71
Positive
Endo agreed to acquire Penwest at $5.00/share cash, ~$144M enterprise value. Eliminates royalty stream on OPANA ER. Closed November 4, 2010.
Did it work? Outcome assessment
Strategic verdict
Partially Achieved
Financial impact
Impaired/Written Down
Pipeline outcome
Assets Terminated
Assessment window: 10yr post-close.
Key facts
- Announced Aug 09, 2010
- Closed Nov 04, 2010
- Deal value $144M
- Deal type Acquisition/Merger
- Therapeutic area Chronic pain
- Indications Chronic pain
- Key assets OPANA ER (oxymorphone) royalty stream
- Mechanism Opioid analgesic; controlled-release technology (TIMERx)
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals